Hong Kong · Delayed Price · Currency is HKD CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 14.14 billion. The enterprise value is 13.14 billion.
| Market Cap | 14.14B |
| Enterprise Value | 13.14B |
Important Dates
The next confirmed earnings date is Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has decreased by -4.49% in one year.
| Current Share Class | 132.67M |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | -4.49% |
| Shares Change (QoQ) | -2.22% |
| Owned by Insiders (%) | 31.01% |
| Owned by Institutions (%) | 9.46% |
| Float | 160.04M |
Valuation Ratios
The trailing PE ratio is 152.40 and the forward PE ratio is 29.50.
| PE Ratio | 152.40 |
| Forward PE | 29.50 |
| PS Ratio | 10.31 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 292.14 |
| EV / Sales | 9.61 |
| EV / EBITDA | 128.84 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.20.
| Current Ratio | 4.39 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 10.64 |
| Debt / FCF | n/a |
| Interest Coverage | -3.38 |
Financial Efficiency
Return on equity (ROE) is 0.82% and return on invested capital (ROIC) is -2.05%.
| Return on Equity (ROE) | 0.82% |
| Return on Assets (ROA) | -0.80% |
| Return on Invested Capital (ROIC) | -2.05% |
| Return on Capital Employed (ROCE) | -1.52% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | 39,927 |
| Employee Count | 1,175 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.88 |
Taxes
In the past 12 months, HKG:6185 has paid 7.44 million in taxes.
| Income Tax | 7.44M |
| Effective Tax Rate | 13.68% |
Stock Price Statistics
The stock price has decreased by -34.55% in the last 52 weeks. The beta is 1.13, so HKG:6185's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -34.55% |
| 50-Day Moving Average | 29.89 |
| 200-Day Moving Average | 29.91 |
| Relative Strength Index (RSI) | 44.31 |
| Average Volume (20 Days) | 5,719,634 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 1.43 billion and earned 46.91 million in profits. Earnings per share was 0.19.
| Revenue | 1.43B |
| Gross Profit | 1.06B |
| Operating Income | -106.96M |
| Pretax Income | 54.35M |
| Net Income | 46.91M |
| EBITDA | 100.00M |
| EBIT | -106.96M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 2.13 billion in cash and 1.13 billion in debt, with a net cash position of 996.44 million or 4.03 per share.
| Cash & Cash Equivalents | 2.13B |
| Total Debt | 1.13B |
| Net Cash | 996.44M |
| Net Cash Per Share | 4.03 |
| Equity (Book Value) | 5.75B |
| Book Value Per Share | 23.26 |
| Working Capital | 2.88B |
Cash Flow
In the last 12 months, operating cash flow was -31.12 million and capital expenditures -192.81 million, giving a free cash flow of -223.92 million.
| Operating Cash Flow | -31.12M |
| Capital Expenditures | -192.81M |
| Depreciation & Amortization | 210.67M |
| Net Borrowing | -1.07B |
| Free Cash Flow | -223.92M |
| FCF Per Share | -0.91 |
Margins
Gross margin is 74.17%, with operating and profit margins of -7.50% and 3.29%.
| Gross Margin | 74.17% |
| Operating Margin | -7.50% |
| Pretax Margin | 3.81% |
| Profit Margin | 3.29% |
| EBITDA Margin | 7.01% |
| EBIT Margin | -7.50% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 79.20% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.49% |
| Shareholder Yield | 4.49% |
| Earnings Yield | 0.66% |
| FCF Yield | -1.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:6185 is 47.37, which is 63.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 47.37 |
| Price Target Difference | 63.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 24.22% |
| EPS Growth Forecast (3Y) | 167.68% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:6185 has an Altman Z-Score of 4.53 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.53 |
| Piotroski F-Score | 3 |